6.
Brusq J, Ancellin N, Grondin P, Guillard R, Martin S, Saintillan Y
. Inhibition of lipid synthesis through activation of AMP kinase: an additional mechanism for the hypolipidemic effects of berberine. J Lipid Res. 2006; 47(6):1281-8.
DOI: 10.1194/jlr.M600020-JLR200.
View
7.
Ma X, Iwanaka N, Masuda S, Karaike K, Egawa T, Hamada T
. Morus alba leaf extract stimulates 5'-AMP-activated protein kinase in isolated rat skeletal muscle. J Ethnopharmacol. 2008; 122(1):54-9.
DOI: 10.1016/j.jep.2008.11.022.
View
8.
Nemoto H, Katagiri A, Kamiya M, Kawamura T, Matsushita T, Matsumura K
. Synthesis of paclitaxel-BGL conjugates. Bioorg Med Chem. 2012; 20(18):5559-67.
DOI: 10.1016/j.bmc.2012.07.031.
View
9.
Kaeberlein M, McDonagh T, Heltweg B, Hixon J, Westman E, Caldwell S
. Substrate-specific activation of sirtuins by resveratrol. J Biol Chem. 2005; 280(17):17038-45.
DOI: 10.1074/jbc.M500655200.
View
10.
Miura S, Kai Y, Kamei Y, Bruce C, Kubota N, Febbraio M
. Alpha2-AMPK activity is not essential for an increase in fatty acid oxidation during low-intensity exercise. Am J Physiol Endocrinol Metab. 2008; 296(1):E47-55.
DOI: 10.1152/ajpendo.90690.2008.
View
11.
de Boer V, de Goffau M, Arts I, Hollman P, Keijer J
. SIRT1 stimulation by polyphenols is affected by their stability and metabolism. Mech Ageing Dev. 2006; 127(7):618-27.
DOI: 10.1016/j.mad.2006.02.007.
View
12.
Moon H, Chung C, Lee H, Kim T, Choi Y, Cho C
. Inhibitory effect of (-)-epigallocatechin-3-gallate on lipid accumulation of 3T3-L1 cells. Obesity (Silver Spring). 2007; 15(11):2571-82.
DOI: 10.1038/oby.2007.309.
View
13.
Woods A, Johnstone S, Dickerson K, Leiper F, Fryer L, Neumann D
. LKB1 is the upstream kinase in the AMP-activated protein kinase cascade. Curr Biol. 2003; 13(22):2004-8.
DOI: 10.1016/j.cub.2003.10.031.
View
14.
Murase T, Misawa K, Haramizu S, Hase T
. Catechin-induced activation of the LKB1/AMP-activated protein kinase pathway. Biochem Pharmacol. 2009; 78(1):78-84.
DOI: 10.1016/j.bcp.2009.03.021.
View
15.
Jorgensen S, Viollet B, Andreelli F, Frosig C, Birk J, Schjerling P
. Knockout of the alpha2 but not alpha1 5'-AMP-activated protein kinase isoform abolishes 5-aminoimidazole-4-carboxamide-1-beta-4-ribofuranosidebut not contraction-induced glucose uptake in skeletal muscle. J Biol Chem. 2003; 279(2):1070-9.
DOI: 10.1074/jbc.M306205200.
View
16.
Fujii N, Hirshman M, Kane E, Ho R, Peter L, Seifert M
. AMP-activated protein kinase alpha2 activity is not essential for contraction- and hyperosmolarity-induced glucose transport in skeletal muscle. J Biol Chem. 2005; 280(47):39033-41.
DOI: 10.1074/jbc.M504208200.
View
17.
Turner N, Li J, Gosby A, To S, Cheng Z, Miyoshi H
. Berberine and its more biologically available derivative, dihydroberberine, inhibit mitochondrial respiratory complex I: a mechanism for the action of berberine to activate AMP-activated protein kinase and improve insulin action. Diabetes. 2008; 57(5):1414-8.
DOI: 10.2337/db07-1552.
View
18.
Zheng J, Ramirez V
. Inhibition of mitochondrial proton F0F1-ATPase/ATP synthase by polyphenolic phytochemicals. Br J Pharmacol. 2000; 130(5):1115-23.
PMC: 1572158.
DOI: 10.1038/sj.bjp.0703397.
View
19.
Ahn J, Lee H, Kim S, Park J, Ha T
. The anti-obesity effect of quercetin is mediated by the AMPK and MAPK signaling pathways. Biochem Biophys Res Commun. 2008; 373(4):545-9.
DOI: 10.1016/j.bbrc.2008.06.077.
View
20.
Suchankova G, Nelson L, Gerhart-Hines Z, Kelly M, Gauthier M, Saha A
. Concurrent regulation of AMP-activated protein kinase and SIRT1 in mammalian cells. Biochem Biophys Res Commun. 2008; 378(4):836-41.
PMC: 2764524.
DOI: 10.1016/j.bbrc.2008.11.130.
View